Table 3.
Proportions of patients taking medication at baseline and during follow up
| Intervention group | Control group | |||||||
| Baseline | 6 months | 12 months | 18 months | Baseline | 6 months | 12 months | 18 months | |
| Number | 103 | 67 | 56 | 50 | 105 | 83 | 74 | 66 |
| Mean furosemide dose (mg/day) | 114 | 92 | 77 | 81 | 120 | 106 | 106 | 89 |
| Furosemide (%) | 94 | 93 | 91 | 92 | 92 | 95 | 95 | 87 |
| β Adrenoblockers (%) | 52 | 57 | 55 | 57 | 52 | 58 | 62 | 63 |
| ACE inhibitors (%) | 72 | 76 | 66 | 63 | 76 | 80 | 77 | 68 |
| Digitalis (%) | 54 | 49 | 45 | 40 | 48 | 48 | 36 | 40 |
| Aldosterone antagonists (%) | 21 | 18 | 14 | 16 | 18 | 18 | 15 | 18 |
There were no significant differences within or between the two study groups during the course of the study.